QLI

Qilian International Holding Group Limited

Price

return (12m)

0.00%

p/e

308.85

p/bv

4.52

DIVIDEND YIELD

0.00%

QLI price

Qilian International Holding Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment QLI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals QLI

Valuation

P/E

308.85

Sector -2.23

Industry -6.43

P/BV

4.52

Sector 2.14

Industry 1.86

P/Revenue (PSR)

Sector 1.98

Industry 3.13

EV/EBITDA

Sector -24.41

Industry -31.34

EV/EBIT

Sector -37.37

Industry -46.59

P/EBITDA

84.89

Sector -0.01

Industry -2.95

P/EBIT

135.52

Sector -2.00

Industry -5.83

P/Total Assets

3.77

Sector 1.15

Industry 1.22

P/Net Current Assets

Sector -10.54

Industry -7.84

P/Working Capital

Sector 0.02

Industry 0.99

EPS

0.02

Sector -0.94

Industry -1.44

BVPS

1.20

Sector 3.93

Industry 2.20

Efficiency

Gross Margin

0.00%

Sector 44.21%

Industry 46.60%

EBITDA Margin

Sector -312.85%

Industry -17,123,075.56%

EBIT Margin

Sector -193.57%

Industry -17,075,545.37%

Operating Margin

0.00%

Sector -25.72%

Industry -34.57%

Net Profit Margins

0.00%

Sector -30.17%

Industry -37.93%

Asset Turnover

Sector 0.12

Industry 0.05

Profitability

ROE

1.46%

Sector -35.35%

Industry -48.50%

ROA

1.22%

Sector -29.04%

Industry -52.44%

ROIC

Sector -439.00%

Industry -520.61%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 1.87

Industry 2.33

Net Debt / EBITDA

Sector -1.64

Industry -1.99

Net Debt / EBIT

Sector -0.81

Industry -1.80

Net Debt / Equity

Sector -0.35

Industry -0.87

Gross Debt / Equity

Sector 0.17

Industry -0.18

Equity/Assets

0.83

Sector 0.42

Industry 0.47

Liabilities/Assets

0.83

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-20.89%

Sector -

Industry -

FAIR VALUE OF Qilian International Holding Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$0.73

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals QLI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
QLI	308.85	4.52	1.46%	0.00%	$193.41 M	0.00%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

QLI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/24/2023	03/06/2023	0.25000000

ABOUT Qilian International Holding Group

Qilian International Holding Group Limited

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2021

Time since IPO - 5 years

292

Employees

Qilian International Holding Group Limited (United States) is listed on the Nasdaq and has a market capitalization of $193.41 million, with shareholders equity totaling $42.79 million.

The company employs approximately 292 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Qilian International Holding Group Limited reported $- in revenue, generating net income of $626.21 Thousand.

Key financial metrics include a P/E ratio of 308.85, a price-to-book (P/B) ratio of 4.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QLI.

Market cap

$193.41 million

Net worth

$42.79 million

$42,792,133.00

Assets

$51.26 million

$51,257,994.00

Total Shares Outstanding

35.75 million

35,750,000

Average Daily Trading Volume

$17.12 Thousand

$17,121.56

Sector

Health

Industry

Pharmaceutical Products

QLI

QLI revenue and profits

Financial Results QLI

DRAG THE FRAME TO SEE MORE DATA

QLI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.07 87,21% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$291.02 2,28% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$64.08 138,57% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$381.15 67,01% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$44.00 --7,57% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,197.53 58,30% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$389.62 15,17% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$156.11 36,98% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06